What Is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in cells and is fundamental to a wide range of metabolic processes.

One of its best-known roles is participating in redox reactions, where NAD+ and NADH act as an interconnected electron-transfer pair. This makes NAD+ particularly important in research involving cellular energy metabolism and oxidative processes.

NAD+ also serves as a substrate for enzymes involved in cellular signalling. These include pathways associated with proteins such as sirtuins and PARP enzymes, contributing to the scientific interest surrounding NAD+ biology.

---

NAD+ 1000mg Research Applications

Cellular Energy & Metabolism

NAD+ is closely involved in metabolic pathways that allow cells to process nutrients and generate usable energy, making it relevant to research into cellular metabolism.

Mitochondrial Research

Because NAD+ participates in oxidative metabolism and electron-transfer reactions, it is frequently studied in connection with mitochondrial biology and cellular energy production.

Redox Biology

The NAD+/NADH relationship is an important component of intracellular redox balance and provides a useful area of investigation for researchers examining oxidative and metabolic processes.

Cellular Signalling

NAD+ is also involved in signalling pathways through its role as a substrate for NAD+-dependent enzymes. This broadens its relevance beyond conventional energy metabolism research.

DNA & Cellular Stress Research

NAD+ metabolism is connected with several cellular enzymes involved in DNA damage responses and cellular stress pathways, making it an area of interest in molecular and cellular biology research.

Ageing Biology

NAD+ metabolism is being extensively investigated in ageing research. Scientists are studying how NAD+ availability changes with age and whether manipulation of NAD+ metabolism can influence biological processes associated with ageing.

Importantly, ongoing human research has not established NAD+ supplementation as a proven anti-ageing treatment, and much of the current evidence remains mechanistic, preclinical or focused on NAD+ precursors rather than direct NAD+ administration.